302 related articles for article (PubMed ID: 30030108)
41. Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis.
Wang Q; Xie Z; Wan N; Yang L; Jin Z; Jin F; Huang Z; Chen M; Wang H; Feng J
Chin Med J (Engl); 2023 Jun; 136(11):1278-1290. PubMed ID: 37130223
[TBL] [Abstract][Full Text] [Related]
42. [Alterations of SP-A, SP-D and KL-6 in serum and bronchoalveolar lavage fluid in children with Mycoplasma pneumoniae pneumonia].
Shu LH; Shang YX; Cai XX; Zong ZH; Meng XN; Zhang H; Wang ZJ; Dai B
Zhonghua Er Ke Za Zhi; 2013 Oct; 51(10):779-82. PubMed ID: 24406233
[TBL] [Abstract][Full Text] [Related]
43. [Comparison of biomarkers of pulmonary tuberculosis activity --serum surfactant proteins A and D, KL-6, C-reactive protein, and erythrocyte sedimentation rate].
Enomoto Y; Hagiwara E; Komatsu S; Nishihira R; Baba T; Ogura T
Kekkaku; 2014 Jul; 89(7):637-42. PubMed ID: 25195297
[TBL] [Abstract][Full Text] [Related]
44. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis.
Richards TJ; Kaminski N; Baribaud F; Flavin S; Brodmerkel C; Horowitz D; Li K; Choi J; Vuga LJ; Lindell KO; Klesen M; Zhang Y; Gibson KF
Am J Respir Crit Care Med; 2012 Jan; 185(1):67-76. PubMed ID: 22016448
[TBL] [Abstract][Full Text] [Related]
45. Concentration of surfactant protein D, Clara cell protein CC-16 and IL-10 in bronchoalveolar lavage (BAL) in patients with sarcoidosis, hypersensivity pneumonitis and idiopathic pulmonary fibrosis.
Kucejko W; Chyczewska E; Naumnik W; Ossolińska M
Folia Histochem Cytobiol; 2009; 47(2):225-30. PubMed ID: 19995708
[TBL] [Abstract][Full Text] [Related]
46. [Clinical value of biomarkers in diagnosis and treatment of idiopathic pulmonary fibrosis].
Fan Y; He R; Zou L; Meng J
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):1062-1065. PubMed ID: 32895164
[TBL] [Abstract][Full Text] [Related]
47. Serum and bronchoalveolar lavage fluid endothelin-1 concentrations as diagnostic biomarkers of canine idiopathic pulmonary fibrosis.
Krafft E; Heikkilä HP; Jespers P; Peeters D; Day MJ; Rajamäki MM; Mc Entee K; Clercx C
J Vet Intern Med; 2011; 25(5):990-6. PubMed ID: 21781169
[TBL] [Abstract][Full Text] [Related]
48. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
[TBL] [Abstract][Full Text] [Related]
49. Significance of serum vascular endothelial growth factor level in patients with idiopathic pulmonary fibrosis.
Ando M; Miyazaki E; Ito T; Hiroshige S; Nureki SI; Ueno T; Takenaka R; Fukami T; Kumamoto T
Lung; 2010 Jun; 188(3):247-52. PubMed ID: 20066538
[TBL] [Abstract][Full Text] [Related]
50. Biomarkers and their potential functions in idiopathic pulmonary fibrosis.
Ni S; Song M; Guo W; Guo T; Shen Q; Peng H
Expert Rev Respir Med; 2020 Jun; 14(6):593-602. PubMed ID: 32187497
[No Abstract] [Full Text] [Related]
51. Surfactant protein-A in lung lavage fluid obtained from patients with idiopathic pulmonary fibrosis.
Behera D; Kaur S; Sathyanarayana G; Majumdar S
J Assoc Physicians India; 2002 Nov; 50():1409-12. PubMed ID: 12583473
[TBL] [Abstract][Full Text] [Related]
52. Seasonal variation of serum KL-6 and SP-D levels in bird-related hypersensitivity pneumonitis.
Okamoto T; Tsutsui T; Suhara K; Furusawa H; Miyazaki Y; Inase N
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):364-7. PubMed ID: 25591150
[No Abstract] [Full Text] [Related]
53. Practical management of Idiopathic Pulmonary Fibrosis.
Kishaba T
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):90-8. PubMed ID: 26278687
[TBL] [Abstract][Full Text] [Related]
54. Predicting prognosis in idiopathic pulmonary fibrosis.
Barlo NP; van Moorsel CH; van den Bosch JM; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(2):85-95. PubMed ID: 21319590
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.
Fois AG; Paliogiannis P; Sotgia S; Mangoni AA; Zinellu E; Pirina P; Carru C; Zinellu A
Respir Res; 2018 Mar; 19(1):51. PubMed ID: 29587761
[TBL] [Abstract][Full Text] [Related]
56. Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.
Kakugawa T; Sakamoto N; Sato S; Yura H; Harada T; Nakashima S; Hara A; Oda K; Ishimoto H; Yatera K; Ishimatsu Y; Obase Y; Kohno S; Mukae H
Respir Res; 2016 Jul; 17(1):79. PubMed ID: 27401332
[TBL] [Abstract][Full Text] [Related]
57. Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics.
Yan F; Wen Z; Wang R; Luo W; Du Y; Wang W; Chen X
BMC Pulm Med; 2017 Dec; 17(1):174. PubMed ID: 29212488
[TBL] [Abstract][Full Text] [Related]
58. Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.
Kahloon RA; Xue J; Bhargava A; Csizmadia E; Otterbein L; Kass DJ; Bon J; Soejima M; Levesque MC; Lindell KO; Gibson KF; Kaminski N; Banga G; Oddis CV; Pilewski JM; Sciurba FC; Donahoe M; Zhang Y; Duncan SR
Am J Respir Crit Care Med; 2013 Apr; 187(7):768-75. PubMed ID: 23262513
[TBL] [Abstract][Full Text] [Related]
59. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.
Maher TM; Oballa E; Simpson JK; Porte J; Habgood A; Fahy WA; Flynn A; Molyneaux PL; Braybrooke R; Divyateja H; Parfrey H; Rassl D; Russell AM; Saini G; Renzoni EA; Duggan AM; Hubbard R; Wells AU; Lukey PT; Marshall RP; Jenkins RG
Lancet Respir Med; 2017 Dec; 5(12):946-955. PubMed ID: 29150411
[TBL] [Abstract][Full Text] [Related]
60. [A case of idiopathic pulmonary upper lobe fibrosis complicated by invasive pulmonary aspergillosis].
Fuke S; Betsuyaku T; Oizumi S; Nasuhara Y; Saito H; Yamaguchi E; Nishimura M
Nihon Kokyuki Gakkai Zasshi; 2003 Mar; 41(3):196-201. PubMed ID: 12772600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
